Key facts
- This page summarizes Sam Ropp's Form 4 filing for Singular Genomics Systems, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Sep 2023, 19:03.
Sam Ropp - 15 Sep 2023 Form 4 Insider Report for Singular Genomics Systems, Inc.
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- N/A
- Reported as of
- 15 Sep 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Sep 2023, 19:03:33 UTC
- Prior SEC filing
- 17 Aug 2023
- Next SEC filing
- 18 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dalen Meeter, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sam Ropp filed Form 4 for Singular Genomics Systems, Inc. on 15 Sep 2023.
Change
- Previous filing in this sequence was filed on 17 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OMIC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,187
- Change %
- +100%
- Price
- Shares after
- 8,375
- Date
- 15 Sep 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OMIC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -4,187
- Change %
- -6.7%
- Price
- Shares after
- 58,625
- Date
- 15 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,187
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F2
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F3
The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.